Laboratory examinations also indicated evidence of liver dysfunction [alanine aminotransferase (ALT) 219 U/L and aspartate aminotransferase (AST) 84 U/L] and dyslipidemia with markedly increased triglyceride levels and slightly decreased high-density lipoprotein (HDL) (22.17 mmol/L and 0.52 mmol/L, respectively). The gene discussed is GPT; the disease is Decreased liver function.